Calculi clinical trials

The registry lists 51 studies for Calculi across more than 10 countries. 6 are recruiting or about to start. 21 of them are mainly about Calculi (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 4 narrower conditions too, such as Kidney Calculi: 837 studies, 207 open.

Get an email when these change. Save the Calculi studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 33
Status unknown: 9
Not yet recruiting: 4
Recruiting: 2
Active, not recruiting: 1
Withdrawn: 1

Phase

Phase 4: 8
Phase 1: 5
Phase 2: 4
Phase 3: 2

Where

United States: 13
Canada: 7
Egypt: 5
Pakistan: 3
Italy: 2
Israel: 2

Who runs them

Mansoura University (3) · Zagazig University (2) · University of British Columbia (2) · Omeros Corporation (2) · Hadassah Medical Organization (1) · University of Malaya (1) · Wake Forest University Health Sciences (1) · Pluromed, Inc. (1)

What is being tested here

Drugs under test in Calculi studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Potassium Citrate	1	0	1
Citric Acid	1	0	1
Sodium Bicarbonate	1	0	1
Tamsulosin	0	1	2
Arginine	0	0	1
Cetirizine	0	1	1
Desflurane	0	0	1
Sevoflurane	0	0	1
Tramadol	0	0	1
Potassium	0	1	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026A Comparative Study of Three Ureteral Stenting Strategies After Ureteroscopic Lithotripsy for Upper Urinary Tract Calculi · Second Affiliated Hospital, School of Medicine, Zhejiang University
Jan 2027Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study · SonoMotion

Who these studies take

Of the 2 Calculi studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 51 studies, recruiting or not: 35% stop at 75 or younger and 27% at 65; 16% take children; 2% are for women only and 0% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Calculi studies take

Of 16 interventional studies with no phase under Calculi, half reached primary completion within 42 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	42 mo23–60 · 16 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.